SS
TRIB

SBI Securities’s Trinity Biotech TRIB Stock Holding History

SBI Securities’s Portfolio TRIB Stock Details TRIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-10
Closed -$7 – 4315
2025
Q2 		$7 Hold
10
– – ﹤0.01% 4045
2025
Q1 		$6 Buy
+10
New +$8 ﹤0.01% 4027

Other funds holding TRIB

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
HAIM
Hunter Associates Investment Management Pittsburgh, Pennsylvania $756M AUM 19.99% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
CAPTRUST Financial Advisors
CAPTRUST Financial Advisors Raleigh, North Carolina $57.3B AUM 18.32% 1-Year Est. Return
MAWA
Moss Adams Wealth Advisors Seattle, Washington $1.37B AUM 19.97% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
BCM
Becker Capital Management Portland, Oregon $3.4B AUM 24.68% 1-Year Est. Return

SBI Securities's TRIB Position: Q3 2025 in Review

SBI Securities sold out of Trinity Biotech (TRIB) in Q3 2025, closing a stake of 10 shares — an estimated $7 sold.

SBI Securities first reported a position in TRIB in Q1 2025 and held it in 2 quarters. The position peaked at $7 in Q2 2025. 28 funds tracked by Wall St. Rank hold TRIB as of Q3 2025.

  • SBI Securities reported no remaining Trinity Biotech position as of Q3 2025 after selling out during the quarter.
  • SBI Securities sold 10 Trinity Biotech shares in Q3 2025, an estimated $7.
  • SBI Securities first reported a position in Trinity Biotech in Q1 2025 and held it in 2 quarters.
  • SBI Securities's Trinity Biotech position peaked at $7 in Q2 2025.
  • 28 funds tracked by Wall St. Rank held Trinity Biotech as of Q3 2025.

Based on SBI Securities's 13F filing for Q3 2025, filed 5 Nov 2025.